# A Multi-center Retrospective Study of INO Treating B-ALL

> **NCT07238907** · — · ACTIVE_NOT_RECRUITING · sponsor: **Ruijin Hospital** · enrollment: 102 (actual)

## Conditions studied

- Acute Lymphoblastic Leukaemia
- Acute Lymphoblastic Leukaemias (ALL)
- Inotuzumab Ozogamicin
- Venetoclax

## Interventions

- **DRUG:** Inotuzumab Ozogamicin

## Key facts

- **NCT ID:** NCT07238907
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-06-01
- **Primary completion:** 2025-06-30
- **Final completion:** 2026-07-31
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2025-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07238907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07238907, "A Multi-center Retrospective Study of INO Treating B-ALL". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07238907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*